Related Experiment Video
Updated: Aug 17, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
Published on: July 3, 2014
Intracerebral hemorrhage
1Assistant Professor of Neurology, Stroke Institute, University of Pittsburgh Medical Center, PA 15213, USA.
Insights
Intracerebral hemorrhage (ICH) remains a leading cause of stroke-related death and disability, particularly in young Black individuals. Despite diagnostic advances, effective treatments are lacking, necessitating urgent clinical trials for new therapeutic strategies.
Area of Science:
- Neurology
- Neurosurgery
- Public Health
Background:
- Intracerebral hemorrhage (ICH) accounts for a significant proportion of strokes, leading to high rates of morbidity and mortality.
- This is particularly pronounced in young Black populations.
- Despite advances in diagnostic imaging like CT scans, patient outcomes have not significantly improved.
Purpose of the Study:
- To highlight the urgent need for effective therapeutic interventions for ICH.
- To emphasize the lack of proven treatments despite aggressive medical and surgical interventions.
- To underscore the importance of timely treatment and the necessity for large-scale clinical trials.
Main Methods:
- Review of current diagnostic and therapeutic approaches for ICH.
- Analysis of existing clinical trial data regarding treatment efficacy.
- Identification of emerging therapeutic strategies from experimental and clinical research.
Main Results:
- No current therapeutic modality has demonstrated a clear benefit on long-term outcomes in randomized trials.
- Aggressive interventions are often employed due to the critical nature of ICH presentations.
- Emerging research suggests potential new therapeutic strategies, with time to treatment being a critical factor.
Conclusions:
- Large, prospective, randomized, placebo-controlled trials are essential.
- These trials should evaluate current treatment options and investigate novel therapeutic modalities.
- Addressing the high burden of ICH requires robust scientific investigation and evidence-based treatment strategies.
Abstract:
Intracerebral hemorrhage (ICH) represents a significant fraction of all strokes and causes a disproportionate amount of stroke related morbidity and mortality, especially in young blacks. While diagnosis of this disorder has greatly improved in the CT era, morbidity and mortality remain essentially unchanged. Not one currently utilized therapeutic modality has been clearly associated with a beneficial effect on long term outcome in small prospective randomized treatment trials for ICH. In spite of the lack of scientific data regarding therapy, patients often require aggressive medical and surgical intervention because of the life-threatening presentation of many patients. Recent clinical and experimental ICH research has identified a number of potentially effective new therapeutic strategies, and time to treatment is likely to be very important as it is for ischemic stroke. Large prospective, randomized, placebo controlled trials to examine the judicious application of current therapeutic modalities, and to investigate the potential benefit of proposed new treatment modalities, are long overdue.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology

